Enterprise Value
5.051M
Cash
30.35M
Avg Qtr Burn
-8.807M
Short % of Float
0.62%
Insider Ownership
39.63%
Institutional Own.
12.01%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
BIV201 Details Ascites | Phase 3 Initiation | |
NE3107 Details Alzheimer's disease | Phase 3 Initiation | |
Bezisterim (NE3107) Details Parkinson's disease | Phase 2b Initiation |